Search alternatives:
significant substantial » significant potential (Expand Search), significant spatial (Expand Search)
substantial decrease » substantial increase (Expand Search), substantially increased (Expand Search)
trend decrease » teer decrease (Expand Search)
mean decrease » a decrease (Expand Search)
Showing 1 - 20 results of 21,468 for search '(( significant substantial decrease ) OR ( significant ((trend decrease) OR (mean decrease)) ))', query time: 0.51s Refine Results
  1. 1
    The number of gauging cross-sections where a statistically significant decreasing trend was identified.

    The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

    Published 2024
    “…<p>The number of gauging cross-sections where a statistically significant decreasing trend was identified.</p>…”
    Save to List
    Saved in:
  2. 2
    Mean decrease Gini score by Tweet and user characteristics.

    Mean decrease Gini score by Tweet and user characteristics. by Gray Babbs (16648894)

    Published 2023
    Save to List
    Saved in:
  3. 3
    Trends of growth stability index (A), mean productivity index (B), stress tolerance index (C), and harmonic mean (D).

    Trends of growth stability index (A), mean productivity index (B), stress tolerance index (C), and harmonic mean (D). by Nadia Khater (22553166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Trends in mean serum lipid profiles in patients with type 2 diabetes.

    Trends in mean serum lipid profiles in patients with type 2 diabetes. by Amirhossein Yadegar (13922190)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 5
    Trends in mean serum lipid profiles in patients with type 2 diabetes.

    Trends in mean serum lipid profiles in patients with type 2 diabetes. by Amirhossein Yadegar (13922190)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 6
    Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Cohesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>.

    Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels<sup>b'*'</sup>. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  10. 10
    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  11. 11
    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 12
    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of sulfamethoxazole-trimethoprim therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 13
    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of third-generation cephalosporin therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 14
    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4.

    Trends in the days of amoxicillin and amoxicillin-clavulanate therapy per 100 patients, by month, during Phases 1 to 4. by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 15
    GLS inhibition decreases IL-1β secretion <i>in vitro</i>.

    GLS inhibition decreases IL-1β secretion <i>in vitro</i>. by Bárbara Ponzilacqua-Silva (17002156)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean 

    Line graph showing the increase or decrease in the average number of bee swarms caught over the past three years (Mean  by Beatrice T. Nganso (4114768)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in in-hospital mortality by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 18
    Distribution of the same ingredient across different IDDSI levels (Percentages and frequencies) and statistical significance analysis (Chi-square analysis).

    Distribution of the same ingredient across different IDDSI levels (Percentages and frequencies) and statistical significance analysis (Chi-square analysis). by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4).

    Trends in the length of hospital stay by month during the pre-intervention period (Phase 1) and interventional period (Phases 2–4). by Naoya Itoh (6029276)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 20
    PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils.

    PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. by Jiayu Liu (3951515)

    Published 2022
    Save to List
    Saved in:

Search Tools: